# A Study to Evaluate the Effect of a Single-Dose Intravenous Administration of MEDI-528

> **NCT00483041** · PHASE2 · TERMINATED · sponsor: **MedImmune LLC** · enrollment: 11 (actual)

## Conditions studied

- Asthma

## Interventions

- **OTHER:** PLACEBO
- **BIOLOGICAL:** MEDI528 9 mg/kg

## Key facts

- **NCT ID:** NCT00483041
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-07
- **Primary completion:** 2008-10
- **Final completion:** 2009-06
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Study is replaced by MI-CP198 per CPM.
- **Last updated:** 2014-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00483041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00483041, "A Study to Evaluate the Effect of a Single-Dose Intravenous Administration of MEDI-528". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00483041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*